Sun.Mar 10, 2024

article thumbnail

What Conventional Acne Treatments Get Wrong

Nutritional Aesthetics Alliance

Acne. It’s one of the most common reasons people seek help from skin professionals across modalities, whether it’s from a dermatologist, (a)esthetician, nutritionist, health coach, herbalist, acupuncturist, what have you. Like most skin conditions, acne doesn’t have just one cause or one treatment that will work–it can be complicated.

article thumbnail

Johnson & Johnson Reveals Promising Results for JNJ-2113 in FRONTIER 2 Study

Dermatology Times

Lloyd Miller, MD, PhD, delves into the new data demonstrating high rates of skin clearance over 52 weeks in adults with moderate to severe plaque psoriasis.

81
article thumbnail

15 Advanced Education Courses to Look Up To at The Skin Games 2024 Live Event Part II

The Skin Games

Looking to refine your skills and expand your knowledge in the skincare industry? The Skin Games 2024 Live Event Part II offers a wide range of advanced education courses designed to elevate your practice and boost your success.

article thumbnail

Discussing Late-Breaking INTEGUMENT-PED Data With Arcutis' Chief Medical Officer, Patrick Burnett, MD, PhD, FAAD

Dermatology Times

Burnett recently spoke with Dermatology Times to discuss the background, methods, and findings of the late-breaking INTEGUMENT-PED data, as well as its potential real-world and clinical implications.

Office 74
article thumbnail

Introducing The Repêchage T-Zone Classic Facial Endorsed by CIDESCO International

Lydia Sarfati

Join Lydia Sarfati as we demonstrate the latest addition to our exclusive treatment lineup – the Repêchage T-Zone Classic Facial, a CIDESCO International endorsed procedure. This innovative facial is specially crafted to target and transform the most problematic areas of your skin, leaving you with a flawless, radiant complexion. This webinar will include information on: – Ingredients and treatments to truly address combination skin to help eliminate oiliness in the T-Zone while maintainin

Facials 52
article thumbnail

Navigating Finances in Dermatology: Top 5 Considerations for Dermatologists

Dermatology Times

In an exclusive interview with Gary Dudzik, he shared top 5 considerations dermatology clinicians should have when choosing financial services for their practices and overall financial goals.

More Trending

article thumbnail

How is Artificial Intelligence Growing Up?

Dermatology Times

Joseph Zabinski, PhD, MEM, of OM1, shares insights at AAD into how artificial intelligence can mature and be a positive tool for disease detection.

Tools 81
article thumbnail

Protected: The Lowdown on Molluscum

The Dermatology Digest

This content is password protected. To view it please enter your password below: Password: The post Protected: The Lowdown on Molluscum appeared first on The Dermatology Digest.

article thumbnail

Trends in Cosmeceuticals and Nutraceuticals: Exosomes and Adaptogens Take Center Stage

Dermatology Times

Discover the science behind cosmeceutical advancements and the importance of staying informed for enhanced patient care with Zoe Diana Draelos, MD.

74
article thumbnail

Late-breaking Data: Congenital Ichthyosis Treatment Update

The Dermatology Digest

Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, discusses findings from the phase 3 maximal use arm of the ASCEND Trial that looked at topical isotretinoin 0.05% (TMB-001) in congenital ichthyosis. The upshot? Topical isotretinoin, even when applied to 90% of a patient’s body surface area, showed minimal systemic absorption.

article thumbnail

Late-Breaking Data: Long-Term Safety and Efficacy of Largest Prurigo Nodularis Study Ever Conducted

Dermatology Times

Shawn Kwatra, MD, presented late-breaking data at AAD 2024 on the largest prurigo nodularis and nemolizumab clinical trial, OLYMPIA.

Safety 78
article thumbnail

Sneak Peek Inside the CSU Treatment Pipeline

The Dermatology Digest

Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA, reviews currently available and emerging treatments for chronic spontaneous urticaria (CSU), including dupilumab (Dupixent, Sanofi, and Regeneron Pharmaceuticals), remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase (BTK) inhibitor, other BTK inhibitors, interleukin 5 (IL-5) inhibitors and C-kit blockers.

article thumbnail

Lawrence Eichenfield, MD: Outlining Late-Breaking INTEGUMENT-PED Data for Roflumilast in Pediatric Patients

Dermatology Times

Eichenfield discusses the late-breaking data on roflumilast cream 0.05% in the pediatric patient population and its implications.

76
article thumbnail

The Silent Epidemic of Excess Iron

Aesthetics Advisor

In this interview below, Christy Sutton, D.C., reviews the dangers of excessive iron. While most doctors look for iron deficiency, few ever pay attention to elevated iron. Sutton is the author of two books, “ Genetic Testing: Defining Your Path to a Personalized Health Plan: An Integrative Approach to Optimize Health ,” and “ The Iron Curse, Is Your Doctor Letting High Iron Destroy Your Health?

article thumbnail

Adam Friedman, MD, FAAD: Exploring the Utilization of Immunomodulators as Therapeutic Interventions in Chronic Spontaneous Urticaria

Dermatology Times

In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.

article thumbnail

Eczema: Gene Based Approaches (2024)

Aesthetics Advisor

In the following sections, we’ll outline gene-based approaches that may help you deal with eczema. Read on to find out what you can do to manage this condition. The below strategies are not meant to replace your standard medical treatment. Make sure to consult with your doctor before making any significant changes to your day-to-day routine. This post has more than 300 evidence based references.

Eczema 36
article thumbnail

Late-Breaking Data: Long-Term Safety and Efficacy of Delgocitinib Cream for Chronic Hand Eczema

Dermatology Times

Melinda Gooderham, MSc, MD, FRCPC, provided insights into the significance of the DELTA 3 extension data presented at AAD 2024.

Eczema 74
article thumbnail

Best Foods to Avoid for Eczema 2024

Aesthetics Advisor

Randomized, double-blind, controlled trials suggest that excluding certain foods, such as eggs and chicken, can significantly improve atopic dermatitis. Infants of mothers randomized to cut out eggs, milk, and fish were significantly less likely to have eczema even years later. Eczema, also known as atopic dermatitis, is a chronic inflammatory skin disease.

Eczema 36
article thumbnail

Alan Mendelsohn, MD, Shares Insights Into Congenital Ichthyosis Patient Care and the Development of TMB-001

Dermatology Times

The congenital ichthyosis session the 2024 AAD Annual Meeting covered real-world patient cases and treatments on the horizon.

article thumbnail

Pro Tips and Tricks to Take the Sting Out of Pediatric Dermatologic Procedures

The Dermatology Digest

From distraction techniques to pharmacologic measures, Peter A. Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, shares pearls on keeping pediatric patients comfortable during common dermatologic procedures. More Conference Coverage CSU Is for You Adam Friedman, MD Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and

article thumbnail

Anticipated FDA Approval of Bimekizumab for HS: Insights From Investigator Christopher Sayed, MD

Dermatology Times

The phase 3 studies, BE HEARD I and BE HEARD II, showed significant improvements in skin pain over the 48-week period.

72
article thumbnail

Lebrikizumab Performs Well in AD Patients With Darker Skin Types

The Dermatology Digest

More than two-thirds of people with atopic dermatitis (AD) and darker skin tones treated with lebrikizumab showed improvements in skin clearance and itch relief, according to late-breaking results from a Phase 3 study are being presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego. Lebrikizumab (Ebglyss, Almirall), an interleukin-13 (IL-13) inhibitor, just received European Commission approval this year, and it is making its way down the pike in the US too.

article thumbnail

Surgical Procedures to Consider for Hidradenitis Suppurativa

Dermatology Times

Maria Aleshin, MD, FAAD, presented surgical procedures for HS that can be performed in the office.

Office 78
article thumbnail

79% of Americans Noticed Positive Changes After Using Health Tracking Technology

Aesthetics Advisor

Americans are increasingly taking control of their health via the use of health monitoring technologies, with notable benefits as a result. A Cleveland Clinic survey revealed that 50% of Americans use at least one type of technology to track their health, with most experiencing significant related physical and mental improvements. 1 If you’re considering investing in a fitness tracker or other form of wearable, health-tracking technology, however, there are some caveats to consider, including ef

article thumbnail

2024 AAD Annual Meeting Recap: Day 3

Dermatology Times

Catch up on coverage from the third day of the 2024 American Academy of Dermatology Annual Meeting.

article thumbnail

Vitamin B Complex: Benefits, Deficiency Symptoms and Groups Who Need More

Aesthetics Advisor

Vitamin B complex refers to a group of 8 water-soluble B vitamins and the supplement made from a compound of them. This vitamins work synergistically together and are vital for the human body. Vitamin B complex can be quickly absorbed by the intestine and excreted through renal metabolism. It then acts as a coenzyme in many catabolic and anabolic enzymatic reactions, which play an integral role in cell function.

Diet 36